Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Post-marketing, Open-label, Observational, Non-interventional, Comparative, Controlled, Monocenter Study of the Efficacy and Safety of Mastodinone in Patients With Fibrocystic Breast Disease

NCT05717894 is registered in ClinicalTrials.gov with Nazgul Omarbayeva as lead sponsor.

NCT NCT05717894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05717894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Post-marketing, Open-label, Observational, Non-interventional, Comparative, Controlled, Monocenter Study of the Efficacy and Safety of Mastodinone in Patients With Fibrocystic Breast Disease
Lead sponsor
Nazgul Omarbayeva
Phase
Phase 4
Overall status
Completed
Start date
January 11, 2020
Completion date
June 10, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrocystic breast disease